By chi square tests, we found that the lesion size, chronic pelvic pain score, endometriosis stage and rAFS score were significantly lower in BARD1-positive patients than in BARD1-negative patients (Table 1, P < 0.05). This evidence concerns the gene BARD1 and endometriosis.